Clincosm LogoSign in Get a demo

Stroke

Showing NaN - NaN of 31
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acquired Brain Injury, Stroke, Traumatic Brain Injury Trial in Edmonton (GlenXRose Augmented Reality Acquired Brian Injury

Not yet recruiting
  • Acquired Brain Injury
  • +2 more
  • GlenXRose Augmented Reality Acquired Brian Injury Therapies
  • Edmonton, Alberta, Canada
    Glenrose Rehabilitation Hospital
Jun 8, 2023

Atrial Fibrillation, Stroke, Bleeding Trial in Canada, Germany, United States (Antiplatelet-only strategy, Oral Anticoagulant

Recruiting
  • Atrial Fibrillation
  • +2 more
  • Antiplatelet-only strategy
  • Oral Anticoagulant plus background antiplatelet therapy
  • Little Rock, Arkansas
  • +73 more
Jan 12, 2023

Stroke, Atrial Fibrillation Trial in Canada, Denmark (Investigators can choose from one of four Non-vitamin K oral

Recruiting
  • Stroke
  • Atrial Fibrillation
  • Non-vitamin K oral anticoagulant (NOAC)
  • Concord, New South Wales, Australia
  • +46 more
Oct 21, 2022

Atrial Fibrillation, Stroke Trial in Edmonton (Anticoagulants)

Active, not recruiting
  • Atrial Fibrillation
  • Stroke
  • Edmonton, Alberta, Canada
    University of Alberta
Aug 8, 2022

Stroke Trial in Canada, United States (Apixaban, Aspirin)

Recruiting
  • Stroke
  • Birmingham, Alabama
  • +181 more
Mar 26, 2022

Atrial Fibrillation, Stroke Trial in Worldwide (Apixaban, aspirin)

Active, not recruiting
  • Atrial Fibrillation
  • Stroke
  • Mesa, Arizona
  • +129 more
Aug 25, 2021

GLORIA-AF Registry Program - Second and Third Phases

Completed
Has Results
  • Stroke
  • Atrial Fibrillation
    • Mobile, Alabama
    • +665 more
    Mar 3, 2021

    Stroke, Atrial Fibrillation, Arrhythmias, Cardiac Trial in Calgary, Edmonton (Medtronic Reveal LINQ, Sorin Spiderflash-t)

    Completed
    • Stroke
    • +2 more
    • Medtronic Reveal LINQ
    • Sorin Spiderflash-t
    • Calgary, Alberta, Canada
    • +2 more
    Nov 6, 2020

    Ischemic Attack, Transient, Stroke Trial in Edmonton, Ottawa (Dabigatran)

    Completed
    Has Results
    • Ischemic Attack, Transient
    • Stroke
    • Edmonton, Alberta, Canada
    • +1 more
    Jun 8, 2020

    Stroke, Myocardial Infarction, Diabetes Trial in Worldwide (pioglitazone, )

    Completed
    Has Results
    • Stroke
    • +2 more
    • Birmingham, Alabama
    • +182 more
    Apr 14, 2020

    Stroke, Secondary Prevention Trial in Worldwide (optional ASA as comedication, to ASA, to optional ASA as comedication)

    Completed
    Has Results
    • Stroke
    • Secondary Prevention
    • optional ASA as comedication
    • +5 more
    • Phoenix, Arizona
    • +568 more
    Aug 13, 2019

    Aortic Stenosis, Brain Infarction, Cerebrovascular Accident Trial in Canada, United States (Embol-X Embolic Protection Device,

    Completed
    Has Results
    • Aortic Stenosis
    • +3 more
    • Embol-X Embolic Protection Device
    • CardioGard Cannula
    • Los Angeles, California
    • +17 more
    Apr 26, 2019

    Stroke Trial in Worldwide (Rivaroxaban (Xarelto, BAY59-7939), Acetylsalicylic acid (Aspirin, BAY1019036), Rivaroxaban-Placebo)

    Terminated
    Has Results
    • Stroke
    • Rivaroxaban (Xarelto, BAY59-7939)
    • +3 more
    • Tucson, Arizona
    • +453 more
    Dec 20, 2018

    Stroke, Transient Ischemic Attack, Atrial Fibrillation Trial in Canada (a 30-day ambulatory cardiac event monitor, 24-hour

    Unknown status
    • Stroke
    • +3 more
    • a 30-day ambulatory cardiac event monitor
    • 24-hour Holter
    • Calgary, Alberta, Canada
    • +16 more
    Oct 3, 2018

    Stroke Trial in Canada (rfVIIa, Standard saline solution)

    Completed
    • Stroke
    • rfVIIa
    • Standard saline solution
    • Calgary, Alberta, Canada
    • +14 more
    Oct 3, 2018

    Cerebral Infarction, Brain Ischemia, Stroke Trial in Edmonton (Tenecteplase (TNK) (0.25 mg/kg, to maximum of 25mg))

    Completed
    • Cerebral Infarction
    • +2 more
    • Tenecteplase (TNK) (0.25 mg/kg, to maximum of 25mg)
    • Edmonton, Alberta, Canada
      University of Alberta
    Apr 4, 2018

    Stroke Trial in Edmonton (Sedentary behaviour intervention)

    Completed
    • Stroke
    • Sedentary behaviour intervention
    • Edmonton, Alberta, Canada
      University of Alberta
    Feb 16, 2018

    Stroke Trial in Worldwide (Desmoteplase, Placebo)

    Terminated
    Has Results
    • Stroke
    • Phoenix, Arizona
    • +151 more
    Feb 8, 2017

    Myocardial Infarction, Cardiovascular Death, Atherothrombosis Trial in Worldwide (Ticagrelor 90 mg, Ticagrelor 60 mg, Ticagrelor

    Completed
    Has Results
    • Myocardial Infarction
    • +3 more
    • Ticagrelor 90 mg
    • +2 more
    • Alexander City, Alabama
    • +846 more
    Dec 18, 2015

    Stroke Trial in Worldwide (SUN13837, )

    Withdrawn
    • Stroke
    • Mobile, Alabama
    • +52 more
    Oct 19, 2015

    Stroke Trial in Worldwide (Aggrenox, Clopidogrel , Micardis)

    Completed
    Has Results
    • Stroke
    • Birmingham, Alabama
    • +666 more
    Apr 22, 2014

    Atrial Fibrillation, Stroke, Embolism Trial in Worldwide (Rivaroxaban, Warfarin, Matching for Rivaroxaban arm (Warfarin ))

    Completed
    Has Results
    • Atrial Fibrillation
    • +2 more
    • Birmingham, Alabama
    • +958 more
    Apr 10, 2014

    Stroke Trial in Canada, United States (NA-1, Placebo)

    Completed
    Has Results
    • Stroke
    • Phoenix, Arizona
    • +13 more
    Aug 9, 2013

    Testing the Developmental Origins Hypothesis

    Unknown status
    • Diabetes
    • +2 more
      • New Haven, Connecticut
      • +40 more
      Mar 1, 2012

      Deglutition Disorders, Dysphagia, Stroke Trial in Canada, United States (TOR-BSST© Refresher Training)

      Completed
      • Deglutition Disorders
      • +2 more
      • TOR-BSST© Refresher Training
      • Binghamton, New York
      • +4 more
      Jan 9, 2012